- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2018
- Public Summary Document (PSD) July 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2018 PBAC Meeting - Word
Brentuximab vedotin – July 2018
Brentuximab vedotin: Powder for I.V. infusion 50 mg; Adcetris®
Last updated
9 November 2018